Brain SPECT with Perfusion Radiopharmaceuticals and Dopaminergic System Radiocompounds in Dementia Disorders

Author(s): Susanna Nuvoli, Angela Spanu, Giuseppe Madeddu.

Journal Name: Current Alzheimer Research

Volume 14 , Issue 2 , 2017

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer


As well known, the increase in life expectancy and the better physical condition of people in western countries will lead in the next 20 years to a dramatic development of neurodegenerative diseases, especially of dementia that could be considered one of the most important problems in clinical, social and economic fields for the future. Therefore, the differential diagnosis of the various types of dementia is a critical step for patients, clinicians and researchers since an accurate “in vivo” diagnosis can lead to a better patients management. Neuroimaging techniques and in particular the most diffuse and affordable single photon emission computed tomography (SPECT) have provided useful information about dementia disorders and these methods, on the basis of the recent advances, will have an increasingly important role in research and clinical practice. The purpose of this article is to analyze the different SPECT techniques now available which proved clinically useful in correctly formulating the differential diagnosis of dementia.

Keywords: Brain SPECT, perfusion functional imaging, 123I Ioflupane dopaminegic imaging, dementia differential diagnosis.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Page: [143 - 153]
Pages: 11
DOI: 10.2174/1567205013666161019144406
Price: $58

Article Metrics

PDF: 13